News

Novel liver-targeting drug offers hope for AAT deficiency
- Author:
- Sara Freeman
The investigational drug fazirsiran improved important liver parameters associated with alpha-1-antitrypsin deficiency.
News

New onset-depression after RA diagnosis raises mortality risk ‘more than sixfold’
- Author:
- Sara Freeman
Developing depression after a diagnosis of rheumatoid arthritis substantially increased the risk for death over 10 years in a large Danish...
News

Diagnostic axSpA MRI features differ in men and women
- Author:
- Sara Freeman
The cohort study of German patients with and without the disease found no major sex-specific differences for erosion and bone marrow edema but did...
News

Deucravacitinib and orelabrutinib perform well in early lupus trials
- Author:
- Sara Freeman
Disease activity was reduced by treatment with either of the novel investigational agents in two separate early clinical trials, with further...
News

Methotrexate enhances pegloticase response in uncontrolled gout
- Author:
- Sara Freeman
Greater efficacy and fewer infusion reactions seen with methotrexate-pegloticase combination than pegloticase alone in the placebo-controlled...
News
Izokibep improves multiple psoriatic arthritis symptoms in phase 2 study
- Author:
- Sara Freeman
Greater percentages of patients treated with one of two doses of the novel IL-17 blocker achieved an ACR50 response versus placebo.
News

Updated EULAR recommendations for AAV include new drugs, practices
- Author:
- Sara Freeman
Avacopan and mepolizumab feature in new European recommendations for managing antineutrophil cytoplasmic antibody–associated vasculitis.
News
‘Shielding’ status provides best indicator of COVID-19 mortality in U.K. arthritis population
- Author:
- Sara Freeman
Shielding status was the highest ranked of all the risk factors identified for early mortality from COVID-19.
News
Myositis guidelines aim to standardize adult and pediatric care
- Author:
- Sara Freeman
These are the first guidelines on how to manage adult and pediatric patients with idiopathic inflammatory myopathies (IIM).
News

Reduced-frequency methotrexate monitoring causes no harm
- Author:
- Sara Freeman
Laboratory blood test results were similar despite moving from once every month to about once every 3 months or about once every 5 months during...
News
Use of bone densitometry to grade hip OA could be boon to diagnosis, prognosis
- Author:
- Sara Freeman
A novel, semi-automated scoring system enables dual energy x-ray absorptiometry scans of the hip to be graded and provide useful clinical...
News
Lupus may lead to worse stroke outcomes for women, but not men
- Author:
- Sara Freeman
Women with systemic lupus erythematosus (SLE) were 20% more likely to have a prolonged hospital stay and 28% less likely to have a routine home...
News

IBD risk ‘uncertain’ in biologic-treated AxSpA patients
- Author:
- Sara Freeman
“Enormous uncertainty” surrounds the risk of inflammatory bowel disease associated with biologic treatment in patients with axial...
News
Wearable sensors deemed reliable for home gait assessment in knee OA
- Author:
- Sara Freeman
Remote use of wearable gait sensors appears reliable but yields results slightly different from those achieved in the laboratory, researchers from...
News

OARSI sets sights on classifying early-stage knee OA
- Author:
- Sara Freeman
“Early-stage knee OA classification criteria, we believe are critically required,” Gillian Hawker, MD, MSc, said at the OARSI 2022 World Congress...